Discover the key path to novel cures for cancer
by CRISPR functional genomics in 3D tumor models
Discover the key genetic features of cancer that have real translational impacts
Cancer biomarker is the key to stratify patients for oncology drugs, but the current drug development system misses many potential biomarkers and novel drug targets.
We have combined the power of CRISPR functional genomics with the accuracy/translatability of patient tumor-like cancer models to precisely pinpoint biomarker, synthetic lethality, and resistant mutations for novel cancer drug developments.
Assess the functional contribution of cancer mutations with unrivaled accuracy
Our proprietary tumor-immune co-culture system integrated with CRISPR can systematically assess the functional contribution of cancer mutations for tumor growth, and immune or drug response.
Our Team
We are building a world-class team of scientists and engineers dedicated to designing the revolutionary platform that can fundamentally change the way how cancer drugs are developed.
